News

April 19, 2021April 19, 2021

Stroke With PH Can Lead to Longer Hospital Stays, Greater Risk for Men

News, PH News

Pulmonary hypertension (PH) increases the likelihood of a prolonged hospitalization following an acute ischemic stroke, or a stroke due to a blocked vessel carrying blood to a part of the ... Read more

April 16, 2021April 16, 2021

Fungus Used in Chinese Medicine Eased PAH Damage in Rat Model

News, PAH News

Treatment with a fungus called Ophiocordyceps sinensis eased disease signs and improved survival in a rat model of pulmonary arterial hypertension (PAH), suggesting a potential to treat patients. The findings ... Read more

April 15, 2021April 15, 2021

EveryLife Scholarship Fund Open Until May 7 for Adults With Rare Diseases in US

News, syndicated

The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a rare disease pursue personal goals through training and education. For a ... Read more

April 14, 2021April 14, 2021

Levosimendan Shows Benefits in 84% of Patients in Small PH-HFpEF Trial

News, PH News

Treatment with the investigational medication levosimendan was found to improve exercise tolerance, and some parameters related to heart function, in a small clinical trial of people with pulmonary hypertension and heart ... Read more

April 12, 2021April 14, 2021

Uptravi Can Help PAH Patients at Moderate, High Risk of Death, Registry Data Show

News, PAH News

More than three-quarters (76%) of adults with pulmonary arterial hypertension (PAH) being treated with Uptravi (selexipag) either saw no increase or a decline in their risk of death over one ... Read more

April 9, 2021April 9, 2021

Outcomes Poorer for PH-COPD Than Idiopathic PAH, Registry Data Show

News, PH News

Patients whose pulmonary hypertension is associated with chronic obstructive pulmonary disease (PH-COPD) have a worse clinical status and a poorer outcome than those with idiopathic pulmonary arterial hypertension (IPAH), a study ... Read more

April 7, 2021April 7, 2021

Phase 2 Trial Updates on Sotatercept in Treating PAH Set for ATS 2021

News, PAH News

Treatment with Acceleron Pharma’s sotatercept appears to be effective and generally well tolerated in people with pulmonary arterial hypertension (PAH), according to new data from the ongoing PULSAR and SPECTRA ... Read more

April 5, 2021April 6, 2021

Antiparasitic Shows Potential as PAH Treatment in Preclinical Study

News, PAH News

Diminazene aceturate (DIZE), an approved antiparasitic medication, lessened the development of pulmonary arterial hypertension (PAH) in a rat model, a study has demonstrated. These findings support further investigation of DIZE ... Read more

April 2, 2021April 2, 2021

Low-carb, High-fat Diet Seen to Safely Treat PH With Metabolic Syndrome

News, PH News

A ketogenic diet — one that’s low in carbohydrates and higher in fat — given under medical supervision seems to be safe and effective in treating pulmonary hypertension (PH) when ... Read more

April 1, 2021April 6, 2021

Tyvaso Becomes 1st PH-ILD Treatment Approved in US

News, PH News

Tyvaso (inhaled treprostinil) has become the first treatment approved in the U.S. for people with pulmonary hypertension associated with interstitial lung disease (PH-ILD). The U.S. Food and Drug Administration (FDA) ... Read more